JW Lifescience (234080.KS) Earnings Analysis
JW Lifescience (234080.KS) has no confirmed upcoming earnings date. Trailing P/E 5.94.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 234080.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 234080.KS. This page updates as the calendar is published.
234080.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | 432 KRW | n/a | n/a | n/a |
| 2026-02-02 | 416.77 KRW | n/a | n/a | n/a |
| 2025-05-08 | 394 KRW | n/a | n/a | n/a |
| 2025-02-05 | 1,642.65 KRW | n/a | n/a | n/a |
| 2024-08-02 | 429.91 KRW | n/a | n/a | n/a |
234080.KS valuation and analyst view
| Trailing P/E | 5.94 |
|---|---|
| Trailing EPS | 1,843.09 KRW |
| Price / book | 0.81 |
| Dividend yield | 4.92% |
| Market cap | 168.16B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is JW Lifescience (234080.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 234080.KS. This page updates as the calendar is published.
Did 234080.KS beat earnings last quarter?
Consensus estimate data was not available for 234080.KS's 2026-05-15 report.
What is 234080.KS's current P/E ratio and EPS?
234080.KS trades at a trailing P/E of 5.94 on trailing EPS of 1843.0920113672246 KRW.
What do analysts rate 234080.KS?
234080.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.